Article Details
Retrieved on: 2024-12-13 20:17:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pipeline and Clinical Trials. Sana's pipeline is anchored by its hypoimmune platform, which aims to produce cells that can evade the immune system.
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here